- Cardinal Health (CAH, Financial) launches the Kendall DL™ Multi System for continuous monitoring of cardiac activity, blood oxygen level, and temperature.
- The device's single-patient use design helps reduce cross-contamination and improve clinical workflow efficiency.
- Potential financial benefits for healthcare providers through medical device reprocessing.
Cardinal Health (CAH) has introduced a new medical device in the U.S. healthcare market, the Kendall DL™ Multi System. This innovative system allows for the continuous monitoring of three essential vital signs: cardiac activity, blood oxygen level, and temperature, through a single connection point. Designed for single-patient use, this device aims to minimize cross-contamination risks, which can lead to infections and potential hospital readmissions.
The Kendall DL™ Multi System is crafted with a proprietary design that effectively reduces false alarms and motion-related artifacts in ECG tracings. This advancement improves the efficiency of clinical workflows by allowing healthcare providers to focus on genuine patient issues rather than technical disruptions.
Moreover, the system's eligibility for medical device reprocessing through Cardinal Health offers an added advantage. This process extends the product's lifecycle while maintaining its single-use benefits, offering potential cost savings for healthcare facilities. The improved operational efficiencies and infection control measures could enhance the financial performance of healthcare providers under value-based care models.
Rachel Schott, Global Vice President for Specialty Products at Cardinal Health, highlighted that the Kendall DL portfolio's expansion reflects Cardinal Health's commitment to advancing patient monitoring technology and addressing various clinical and operational challenges. The new Kendall DL™ Multi System reinforces Cardinal Health's position in the medical products segment and provides a recurring revenue opportunity as hospitals adopt this technology for each new patient.
